CSIMarket Company Name, Ticker, Suppliers, else..
 
Autolus Therapeutics Plc  (NASDAQ: AUTL)
 

AUTL's Market share relative to its competitors, as of Q3 2026

As of Q3 2026 (Revenue in Millions of $)

Date modified: 2026-09-11T13:29:05+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months
Q3 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE
A Quarter Before
Q2 2026
Autolus Therapeutics Plc 137.43 0.07% 0.08 % 0.05 %
Gilead Sciences Inc 30,988.00 15.74% 16.44% 8.82%
Bluebird Bio Inc 103.95 0.05% 0.08% 0.04%
Amgen Inc 38,903.00 19.76% 20.52% 11.37%
Novartis Ag 56,674.00 28.79% 28.79% 58.48%
Cabaletta Bio Inc 0.00 0.00% 0.00% 0.00%
39 more competitors available

Sign in to see all competitors for Autolus Therapeutics Plc.

Sign In Create Free Account



AUTL's Market share relative to its competitors, as of Q3 2026 within the Biotechnology & Pharmaceuticals Industry
As of Q3 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE

Q2 2026
Autolus Therapeutics Plc 0.16% 0.10% 0.18 % 0.20 %
Gilead Sciences Inc 35.16% 38.18% 36.46% 33.49%
Bluebird Bio Inc 0.12% 0.11% 0.17% 0.17%
Amgen Inc 44.14% 43.34% 45.53% 43.15%
Cabaletta Bio Inc 0.00% 0.00% 0.00% 0.00%
Arcellx Inc 0.03% 0.07% 0.01% 0.02%
31 more companies available

Sign in to see all industry competitors for Autolus Therapeutics Plc.

Sign In Create Free Account



AUTL's Market share relative to its competitors, as of Q3 2026 within the Healthcare Sector
As of Q3 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2026		 MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
MRQ
Q3 2026		 MARKET SHARE

Q2 2026
Autolus Therapeutics Plc 0.07% 0.04% 0.08 % 0.05 %
Gilead Sciences Inc 15.81% 17.04% 16.50% 8.85%
Bluebird Bio Inc 0.05% 0.05% 0.08% 0.04%
Amgen Inc 19.85% 19.35% 20.61% 11.40%
Novartis Ag 28.92% 27.01% 28.92% 58.67%
Cabaletta Bio Inc 0.00% 0.00% 0.00% 0.00%
37 more companies available

Sign in to see all sector competitors for Autolus Therapeutics Plc.

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Autolus Therapeutics Plc's market divisions, geographic dispersion, segments, products, and services, visit Autolus Therapeutics Plc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.